| Abstrakt: |
Researchers from Abbott Laboratories in Alameda, California, have conducted a study on value-based diabetes care, emphasizing the importance of standardized quality measures to improve clinical outcomes for individuals with diabetes. The study highlights the use of continuous glucose monitoring to measure and enhance quality metrics, particularly focusing on the Glucose Management Indicator as a measure of glucose control. This research, supported by Abbott Laboratories, underscores the benefits of value-based care and the positive impact of continuous glucose monitoring on the lives of individuals with diabetes. [Extracted from the article] |
